|
HY-126037-1mg
|
MedChemexpress LLC
|
(�)-ML 209 [CAS 1334526-14-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-14664F-1mg
|
MedChemexpress LLC
|
(3R,5S)-Fluvastatin (sodium) [CAS 94061-80-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14664F-10mg
|
MedChemexpress LLC
|
(3R,5S)-Fluvastatin (sodium) [CAS 94061-80-0]
|
|
Cancer-programmed cell death
|
|
|
HY-14664F-5mg
|
MedChemexpress LLC
|
(3R,5S)-Fluvastatin (sodium) [CAS 94061-80-0]
|
|
Cancer-programmed cell death
|
|
|
HY-D0934-10mg
|
MedChemexpress LLC
|
(5)6-Carboxytetramethylrhodamine [CAS 117557-83-2]
|
|
|
|
|
HY-D0934-5mg
|
MedChemexpress LLC
|
(5)6-Carboxytetramethylrhodamine [CAS 117557-83-2]
|
|
|
|
|
HY-15464A-10mg
|
MedChemexpress LLC
|
(R)-(-)-Gossypol acetic acid [CAS 866541-93-7]
|
|
Cancer-programmed cell death
|
|
|
HY-15464A-5mg
|
MedChemexpress LLC
|
(R)-(-)-Gossypol acetic acid [CAS 866541-93-7]
|
|
Cancer-programmed cell death
|
|
|
HY-15464A-50mg
|
MedChemexpress LLC
|
(R)-(-)-Gossypol acetic acid [CAS 866541-93-7]
|
|
Cancer-programmed cell death
|
|
|
HY-15464A-1mL
|
MedChemexpress LLC
|
(R)-(-)-Gossypol acetic acid [CAS 866541-93-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-12940A-10mg
|
MedChemexpress LLC
|
(S)-GLPG0974 [CAS 2326220-69-1]
|
|
|
|
|
HY-12940A-25mg
|
MedChemexpress LLC
|
(S)-GLPG0974 [CAS 2326220-69-1]
|
|
|
|
|
HY-12940A-5mg
|
MedChemexpress LLC
|
(S)-GLPG0974 [CAS 2326220-69-1]
|
|
|
|
|
HY-101016-10mg
|
MedChemexpress LLC
|
17-ODYA [CAS 34450-18-5]
|
|
Cancer-programmed cell death
|
|
|
HY-101016-5mg
|
MedChemexpress LLC
|
17-ODYA [CAS 34450-18-5]
|
|
Cancer-programmed cell death
|
|
|
HY-101016-1mL
|
MedChemexpress LLC
|
17-ODYA [CAS 34450-18-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-142972-50ug
|
MedChemexpress LLC
|
19(S)-HETE [CAS 115461-40-0]
|
|
|
|
|
HY-D1630-10mg
|
MedChemexpress LLC
|
4-Di-10-ASP [CAS 95378-73-7]
|
|
|
|
|
HY-D1630-100mg
|
MedChemexpress LLC
|
4-Di-10-ASP [CAS 95378-73-7]
|
|
|
|
|
HY-D1630-25mg
|
MedChemexpress LLC
|
4-Di-10-ASP [CAS 95378-73-7]
|
|
|
|
|
HY-D1630-5mg
|
MedChemexpress LLC
|
4-Di-10-ASP [CAS 95378-73-7]
|
|
|
|
|
HY-D1630-50mg
|
MedChemexpress LLC
|
4-Di-10-ASP [CAS 95378-73-7]
|
|
|
|
|
HY-W094758A-200mg
|
MedChemexpress LLC
|
4-Di-1-ASP [CAS 959-81-9]
|
|
Cancer-programmed cell death
|
|
|
HY-117095-100mg
|
MedChemexpress LLC
|
4-Methylumbelliferyl oleate [CAS 18323-58-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-117095-25mg
|
MedChemexpress LLC
|
4-Methylumbelliferyl oleate [CAS 18323-58-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
